Danaher (DHR) Q1 2026 Earnings
Danaher reported Q1 2026 revenue of $6.0B, missed analyst consensus of $6.0B by $30.6M. Diluted EPS came in at $2.06, beat the $1.94 consensus by $0.12. Danaher reports across 3 business segments, led by Diagnostics, Biotechnology, and Life Sciences.
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Danaher's Q1 2026 earnings report.
Danaher (DHR) reported Q1 2026 earnings on April 21, 2026 before market open.
Danaher reported revenue of $6.0B and diluted EPS of $2.06 for Q1 2026.
Revenue missed the consensus estimate of $6.0B by $30.6M. EPS beat the consensus estimate of $1.94 by $0.12.
You can read the 8-K earnings release (0000313616-26-000109) and the 10-Q periodic report (0000313616-26-000107) directly on SEC EDGAR. The filing index links above go to sec.gov.